- “Global Vaccine Contract Manufacturing market set to grow to $3,831.7m by 2025” says new Visiongain report08 April 2020Pharma
Major fluctuations in demand are seen in the case of influenza, as was seen during pandemics over the last decade. Unexpectedly, the Coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally.
- Visiongain’s analysis indicates that total revenue on Tuberculosis Treatment Drugs Market will be $1,080 million in 2020 due to the World Health Organization strong commitment towards ending TB leading to increase in funding for the research and development both in developed as well and under-developed markets06 April 2020Pharma
Due to maturity of generic drug market, companies are moving away from generics drug into therapeutic market by building strong portfolio for development of anti-tuberculosis drug emphasizing all types of TB cases.
- 30 March 2020Pharma
The global wound care market is big, and only set to grow bigger. Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024. The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …
- “The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report30 March 2020Pharma
Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.
- “Global Stem Cell Technologies and Applications market set to grow to $10903.0m by 2025” says new Visiongain report24 March 2020Pharma
New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.